CEL-SCI Corp is a biotechnology company. It is engaged in the research & development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body\'s natural defense system.
| Website: | www.cel-sci.com |
| Email: | gdewindt@cel-sci.com |
| Main Phone: | +1 703 506-9460 |
| Address: | 8229 Boone Boulevard |
| Address 2: | Suite 802 |
| State: | VA |
| City / Town: | Vienna |
| Country: | USA |
| Postal Code: | 22182 |
| Exchange: | AMX |
| Employees: | 44 |
| NAICS: | Biological Produ |
| Last Price 1.94 | Change $ 0.08 | Change % 4.30 | Tick N/A |
| Bid 1.91 | Bid Size 1,100.00 | Ask 2.02 | Ask Size 3,000.00 |
| Open 1.85 | High 2.05 | Low 1.85 | Prev Close 1.86 |
| Last Trade | Volume 168,884 | 52 Wk Hi 3.92 | 52 Wk Low 1.30 |
| Market Cap 32.2 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 16,601,559.00 | EPS (TTM) -2.79 | PE Ratio N/A | Exchange NYSE American |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 9 | 22 |
| Number of Buys | 9 | 22 |
| Number of Sells | 0 | 0 |
| Net Activity | 125196 | 3209203 |
| Last 10 Buys | Shares |
|---|---|
| Geert R. Kersten | 1,000 |
| Geert R. Kersten | 1,000 |
| Geert R. Kersten | 1,000 |
| Peter R. Young | 1,000 |
| Peter R. Young | 1,000 |
| Geert R. Kersten | 1,000 |
| Geert R. Kersten | 1,000 |
| Geert R. Kersten | 1,000 |
| Peter R. Young | 1,000 |
| Patricia B. Prichep | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| De Maximilian Clara | 1,000 |
| C. Richard Kinsolving | 1,000 |
| Eyal Talor | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 3 | 3 | 3 | 3 |
| Low Target Price Estimate | 3 | 3 | 3 | 3 |
| Mean Target Price Estimate | 3 | 3 | 3 | 3 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 12/16/15 | 12/16/15 | 12/16/15 | 12/16/15 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 10-Q | Quarterly report with a continuing view of a company's financial position | 35 | 2016-08-09 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-07-22 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-19 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-19 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-19 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-19 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-19 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-30 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-30 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-30 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 0 | 0 | 0 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
